In Veritas Medical Diagnostics, Inc.
IVMED · OTC
7/31/2021 | 7/31/2007 | 7/31/2006 | 7/31/2005 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 0.15 | 0.12 |
| FCF Yield | 0.00% | -280.65% | -8.83% | -5.15% |
| EV / EBITDA | 0.00 | -1.46 | -10.66 | -7.33 |
| Quality | ||||
| ROIC | 0.00% | 39.11% | -110.11% | -228.94% |
| Gross Margin | 0.00% | 0.00% | 100.00% | 99.48% |
| Cash Conversion Ratio | 0.20 | 0.35 | 0.30 | 1.96 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | 18.68% | 958,128.43% |
| Free Cash Flow Growth | 0.00% | -17.02% | 10.18% | -153.62% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -1.35 | -2.81 | -0.76 |
| Interest Coverage | 0.00 | 0.00 | 2.24 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 57.00 | -56,780.87 |